CNS Pharmaceuticals, Inc. (CNSP)
2.311
+0.04
(+1.81%)
USD |
NASDAQ |
May 01, 16:00
2.34
+0.03
(+1.25%)
After-Hours: 20:00
CNS Pharmaceuticals Market Cap : 1.875M for May 1, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| ACADIA Pharmaceuticals, Inc. | 3.742B |
| Alnylam Pharmaceuticals, Inc. | 39.51B |
| Savara, Inc. | 1.048B |
| BioMarin Pharmaceutical, Inc. | 10.40B |
| Imunon, Inc. | 5.941M |
Market Cap Related Metrics
| Price to Book Value | 0.4146 |
| Price | 2.311 |
| Earnings Yield | -1.03K% |